TRIM27 expression is associated with poor prognosis in sinonasal mucosal melanoma

Rhinology. 2023 Jun 1;61(3):263-271. doi: 10.4193/Rhin22.405.

Abstract

Background: Tripartite motif-containing 27 (TRIM27) has been implicated in the progression of various cancers. However, the role of TRIM27 in sinonasal mucosal melanoma (SNMM) remains poorly understood.

Materials & methods: We retrospectively examined 28 patients with SNMM treated with between 2003 and 2021. We undertook immunohistochemical analysis of TRIM27, Ki-67, and p-Akt1 expression in SNMM tissues. We also investigated the relationship between TRIM27 expression and clinical characteristics, prognosis, Ki-67 as a tumor growth potential marker, and p-Akt1 as one of the prognostic factors in mucosal melanoma.

Results: TRIM27 expression was significantly higher in T4 disease than in T3 disease and was higher in stage IV than in stage III. Patients with high-TRIM27 SNMM had a significantly poorer prognosis in terms of overall survival (OS) and disease-free survival.There was also a significantly higher rate of distant metastasis. Univariate analysis for OS revealed that TRIM27 and T classification were significant poor prognostic factors. In addition, the Ki-67 positive score and the p-Akt1 total staining score were significantly higher in the high-TRIM27 group than in the low-TRIM27 group.

Conclusions: High TRIM27 expression in SNMM was associated with advanced T classification, poor prognosis and distant metastasis. We suggest that TRIM27 has potential as a novel biomarker for prognosis in SNMM.

MeSH terms

  • DNA-Binding Proteins
  • Humans
  • Ki-67 Antigen
  • Melanoma*
  • Nuclear Proteins
  • Paranasal Sinus Neoplasms* / pathology
  • Prognosis
  • Retrospective Studies

Substances

  • Ki-67 Antigen
  • TRIM27 protein, human
  • DNA-Binding Proteins
  • Nuclear Proteins